Oncternal Therapeutics IncKapitalflussrechnung
| Preis (2025-04-29) | 52W Hoch | 52W Tief |
| 0.5266000000000001 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 1,933 USD | 0 | 0 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 2.959.640 | 0,5 | 0,09 |
Kennzahl in 1000 USD | TTM 2024-06-30 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus operativer Geschäftstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Operative Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Investitionsausgaben (CapEx) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Investitionstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Finanzierungstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Freier Cashflow | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Freie Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |